Hyderabad (Telangana):The Rs 45,848 crore investment projects that could create 83,000 jobs are in the pipeline in Telangana, according to the state government.
The projects are proposed in several sectors, like information technology, automotive, textiles, electronics, life sciences, construction components and food processing.
According to the Industries and Commerce Department's annual report for 2019-20, released here on Tuesday, the industrial policy TS-iPass in the last five years helped the state attract Rs 1,96,404 crore investment and create 13.90 lakh jobs.
The report, released by Minister for Industries and Information Technology K.T. Rama Rao, said 75 per cent of approved industries (9,021 of 12,021) had started operations.
Quoting global real estate firm Knight Frank, it said Hyderabad topped the country's office space market in the second half of 2019 with 8.9 million sq feet transactions against 7 million sq feet in Bengaluru.
Hyderabad continued to dominate as a major hub for life sciences in Asia and as a destination of choice for global companies, contributing over 35 per cent to national pharma production, it said.
With over 800 pharma, biotech and medical technology companies, Telangana has combined enterprise value of $50 billion. The government plans to grow it to $100 billion and create 4 lakh jobs in this decade.
Read:Telangana HC issues notices to Twitter, Centre, State govt on communal tweets
Novartis launched Biome India, a digital innovation hub in Hyderabad, the fourth global facility for the company after San Francisco, Paris and London.
Sahajanand Medical Technologies (SMT) laid the foundation stone for its largest stent manufacturing facility in Asia with Rs 250 crore investment at 20 acres campus in the Medical Devices Park. It will produce around 1.2 million stents and 2 million catheters at full capacity and provide 1,500 jobs.
Genome Valley houses 200 global and national companies with a workforce of 10,000. The key companies added to the cluster in 2019-20 included Sandoz, Syngene, TCI chemicals, Yapan Bio, Vallark Pharma, Sambi Pharma, MAB Tree Biologics, Ritvis Labs and Pheromones.
The central government has granted it the National Investment and Manufacturing Zone status. Master-planning and infrastructure planning are complete and the consent for the establishment has been accorded to the project by the TS Pollution Control Board.